Back to results
US 8,686,225 B2Granted
Monocot seed product comprising a human blood protein
AssigneeVentria Bioscience
InventorsNing Huang, Raymond L. Rodriguez, Frank E. Hagie, David M. Stalker
Life of this patent
Estimating the term…
Abstract
The invention is directed to blood proteins produced in monocot seeds and isolated therefrom for use in therapeutic compositions, as well as to methods of making these isolated blood proteins and to therapeutic compositions comprising them.
Claims16
A method of producing a recombinant human blood protein in monocot plant seeds, comprising the steps of:
- (a) transforming a monocot plant cell with a chimeric gene comprising
- (i) a promoter from the gene of a maturation-specific monocot plant storage protein operably linked to a first DNA sequence encoding a monocot plant seed-specific signal sequence capable of targeting a polypeptide linked thereto to a monocot plant seed endosperm cell, wherein the promoter operably linked to the sequence encoding the signal sequence comprises SEQ ID NO:
- 7;
- and
- (ii) a second DNA sequence encoding the human blood protein, linked in translation frame with the first DNA sequence, wherein the first DNA sequence and the second DNA sequence together encode a fusion protein comprising an N-terminal signal sequence and the human blood protein;
- (b) growing a monocot plant from the transformed monocot plant cell for a time sufficient to produce seeds containing the human blood protein;
- and
- (c) harvesting the seeds from the plant, wherein the human blood protein constitutes at least about 3.0% of the total soluble protein in the harvested seeds.
5 more elements
Dependencies are inferred from the claim text.